Gastro-oesophageal Reflux Disease Trial, Recruiting NCT05697393 Sponsor: Medical College of Wisconsin Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT05697393
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The person must be 18 years of age or older.
  • The person has been diagnosed with gastroesophageal reflux disease (GERD), which is a condition where stomach acid flows back up into the throat or food pipe.
  • The person experiences symptoms such as ear, nose, or throat problems, a long-lasting cough, choking, or food coming back up into the throat.
  • The person has a diagnosis of GERD with symptoms beyond the food pipe, or has been diagnosed with inflammation of the food pipe, a hiatal hernia (where part of the stomach pushes up into the chest), achalasia (a condition affecting swallowing), or spasms of the food pipe.
  • The person must not be pregnant or breastfeeding.

Who may not be able to join:

  • People younger than 18 or older than 85 years of age.
  • People who have sleep apnea or use a CPAP breathing machine.
  • People who have had previous surgery or radiation treatment to the head or neck.
  • People with carotid artery disease, thyroid disease, or a history of stroke or related blood vessel conditions affecting the brain.
  • People who are unable to tolerate having a thin tube passed through the nose.
  • People with serious bleeding disorders where passing a tube through the nose has been considered unsafe by a doctor.
  • People with a known blockage in the food pipe that would prevent a measuring probe from passing through.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Reza Shaker, Medical College of Wisconsin

Phone: 4149556840

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical College of Wisconsin
Registry
ClinicalTrials.gov
Start date
25 January 2011
Est. completion
30 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Symptom Analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov